Literature DB >> 28741448

The Burden and Visit Prevalence of Pediatric Chronic Rhinosinusitis.

Sapideh Gilani1, Jennifer J Shin2.   

Abstract

Objectives Pediatric chronic rhinosinusitis has a substantial impact, but its epidemiology has yet to be elucidated. Our objectives were (1) to determine the associated national visit burden and (2) to assess its frequency relative to other frequent childhood otolaryngological illnesses. Study Design Analysis of national survey databases. Setting Ambulatory care settings in the United States, 2005 to 2012. Subjects and Methods Cases with a diagnosis of chronic rhinosinusitis were assessed in total and as a proportion of all visits reported in National Ambulatory Medical Care Surveys. To place these data into context, results for acute rhinosinusitis, allergic rhinitis, upper respiratory tract infection, and otitis media were also extracted and compared. Data specific to individual age group and calendar year were assessed. Results Chronic rhinosinusitis accounted for 5.6 million visits per annum (range, 3.7-7.5 million) among patients 0 to 20 years of age. Children in the >5- to 10-year-old and >10- to 15-year-old age groups were more likely to be affected ( P < .001). Among all visits, chronic rhinosinusitis was diagnosed in 2.1% (95% confidence interval [CI], 1.9%-2.4%), acute rhinosinusitis in 0.6% (95% CI, 0.5%-0.7%), allergic rhinitis in 2.6% (95% CI, 2.3%-2.8%), upper respiratory tract infection in 8.0% (95% CI, 7.5%-8.4%), and otitis media in 6.7% (95% CI, 6.5%-7.1%). Chronic rhinosinusitis visits were significantly more prevalent than for acute rhinosinusitis (relative risk, 3.40; 95% CI, 2.70-4.10; P < .0001). Among those >15 to 20 years of age, chronic rhinosinusitis was 2.18-fold (95% CI, 1.65-2.70) more frequently diagnosed than otitis media. Conclusions The visit burden from pediatric chronic rhinosinusitis exceeds that of acute rhinosinusitis and equals the burden from allergic rhinitis.

Entities:  

Keywords:  United States; acute rhinosinusitis; age; allergic rhinitis; children; chronic rhinosinusitis; epidemiology; otitis media; pediatric; pediatric otolaryngology; prevalence; sinusitis; upper respiratory tract infection; youth

Mesh:

Year:  2017        PMID: 28741448     DOI: 10.1177/0194599817721177

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  8 in total

Review 1.  Chronic Rhinosinusitis in Children: Pathophysiology, Evaluation, and Medical Management.

Authors:  Jordan Heath; Larry Hartzell; Claire Putt; Joshua L Kennedy
Journal:  Curr Allergy Asthma Rep       Date:  2018-05-29       Impact factor: 4.806

2.  Paranasal sinusitis at the initiation of chemotherapy is a risk factor for invasive fungal disease in children and adolescents with cancer.

Authors:  Kenji Kishimoto; Ryoji Kobayashi; Daiki Hori; Satoru Matsushima; Masato Yanagi; Hirozumi Sano; Daisuke Suzuki; Kunihiko Kobayashi
Journal:  Support Care Cancer       Date:  2021-03-22       Impact factor: 3.603

3.  Functional burden and limitations in children with chronic sinusitis.

Authors:  Brian T Cheng; Stephanie S Smith; Anna B Fishbein
Journal:  Pediatr Allergy Immunol       Date:  2019-10-09       Impact factor: 6.377

4.  Serum, Whole Blood, Hair, and Mucosal Essential Trace Element and Mineral Levels in Children with Verified Chronic Rhinosinusitis Undergoing Functional Endoscopic Sinus Surgery.

Authors:  Svetlana I Alekseenko; Anatoly V Skalny; Sergey A Karpischenko; Alexey A Tinkov
Journal:  Biol Trace Elem Res       Date:  2020-08-12       Impact factor: 3.738

5.  Chronic Rhinosinusitis in Children.

Authors:  Lourdes Quintanilla-Dieck; Derek J Lam
Journal:  Curr Treat Options Pediatr       Date:  2018-09-25

6.  The role of house dust mite immunotherapy in Indonesian children with chronic rhinosinusitis allergy: A randomized control trial.

Authors:  Azwin Mengindra Putera; Zahrah Hikmah; Anang Endaryanto; Margarita Maria Maramis
Journal:  Heliyon       Date:  2021-03-16

7.  The relative proportion of comorbidities among rhinitis and rhinosinusitis patients and their impact on visit burden.

Authors:  Mikko Nuutinen; Annina Lyly; Paula Virkkula; Maija Hytönen; Elmo Saarentaus; Antti Mäkitie; Aarno Palotie; Paulus Torkki; Jari Haukka; Sanna Toppila-Salmi
Journal:  Clin Transl Allergy       Date:  2022-07-21       Impact factor: 5.657

Review 8.  Barrier Impairment and Type 2 Inflammation in Allergic Diseases: The Pediatric Perspective.

Authors:  Michele Ghezzi; Elena Pozzi; Luisa Abbattista; Luisa Lonoce; Gian Vincenzo Zuccotti; Enza D'Auria
Journal:  Children (Basel)       Date:  2021-12-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.